MOH
- Marketing authorisation holder: CHARTWELL MOLECULAR
- Status: likely_approved
Immune Support (CORTISONE) regulatory status in Israel.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH has authorised it.
CHARTWELL MOLECULAR holds the Israeli marketing authorisation.